FDA — authorised 24 February 1975
- Application: NDA017036
- Marketing authorisation holder: BAXTER HLTHCARE
- Local brand name: SODIUM HEPARIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Heptar in United States
FDA authorised Heptar on 24 February 1975
Marketing authorisations
FDA
- Application: NDA017033
- Marketing authorisation holder: ABRAXIS PHARM
- Local brand name: SODIUM HEPARIN
- Indication: INJECTABLE — INJECTION
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Heptar approved in United States?
Yes. FDA authorised it on 24 February 1975; FDA has authorised it.
Who is the marketing authorisation holder for Heptar in United States?
BAXTER HLTHCARE holds the US marketing authorisation.